Yann LeCun and Moderna's Bob Langer join Cellular Intelligence board to bring AI into medicine
arjunrajlab · x · 2026-09-22
Cellular Intelligence, a startup building AI models that predict and eventually control living cell behavior to speed up drug development (starting with a Parkinson's drug), announced that Turing Award winner Yann LeCun, Moderna co-founder Bob Langer, Jens Nielsen, and Fabian Theis joined its scientific advisory board, with Langer also joining the board as observer. The move follows LeCun's recent shift away from Meta toward world-model research.
More from Companies & People
- diginomica: enterprise AI needs buyer trust, not just ROI — plus Dreamforce takeaways — jonerp · 2026-09-22
- OpenAI, Anthropic, and Cognition to launch personal agent platforms within a month — cephaloform · 2026-09-22
- Lux resurfaces 2024 internal memo: "AI and the Death of APIs" — graceisford · 2026-09-22
- Alexandr Wang shows off the Muse logo, says he's "pretty proud" — alexandr_wang · 2026-09-22
- Harvey, valued at $15.5B, goes full-stack AI as commentator declares SaaS dead — viksit · 2026-09-22
- Cerebras CEO: AI frenzy in the Valley is unlike anything we've ever seen — rohanpaul_ai · 2026-09-22